Security key
098070600
Bone Biologics Corp - Common stock, par value $0.001 per share (BBLG)
CUSIP: 098070600
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common stock, par value $0.001 per share
- Total 13F shares
- 455
- Total 13F value
- $1,833
- Share change
- +455
- SEC-reported price per share
- $4.03
- Number of holders
- 4
- Value change
- +$1,833
- Number of buys
- 4
- Shares outstanding
- 1,994,505
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
4
Top holders
4
BBLG full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Bone Biologics Corp SEC filings
Bone Biologics Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 098070600
Recent filing periods:
Ownership snapshot
Top reported holders of BBLG - Bone Biologics Corp - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Don Hankey
Disclosed value leader
Don Hankey
Comparable rows
0/12
Latest evidence
04 Jun 2025
3/4/5
13F
Highest disclosed value: $4,289,289
12 rows are not safely comparable across share classes.
Showing 1-6 of 12 holder rows.
Quick read
Don Hankey has the largest disclosed position value at $4.29M.
0 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Don Hankey's linked filing trail.
Disclosed position value
Top 5
Don Hankey
$4.29M
CITADEL ADVISORS LLC
$556.5K
Bruce Stroever
$49.1K
Phillip Terry Meikle II
$49.1K
Robert E. Gagnon
$49.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Don Hankey |
3/4/5
Chairman of the Board, Director, 10%+ Owner
|
—
mixed-class rows
|
$4,289,289
7,144,395 shares
mixed-class rows
|
— | 27 Mar 2023 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$556,546
35,676 shares
|
— | 31 Mar 2025 |
| Bruce Stroever |
3/4/5
Director
|
—
class O/S missing
|
$49,057
62,894 shares
|
— | 04 Jun 2025 |
| Phillip Terry Meikle II |
3/4/5
Director
|
—
class O/S missing
|
$49,057
62,894 shares
|
— | 04 Jun 2025 |
| Robert E. Gagnon |
3/4/5
Director
|
—
class O/S missing
|
$49,057
62,894 shares
|
— | 04 Jun 2025 |
| Siddhesh Rajendra Angle |
3/4/5
Director
|
—
class O/S missing
|
$49,057
62,894 shares
|
— | 04 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
4
Shares
455
Rows available
4
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q4 2025 Across Filers
Q4 2025 holders
7
Q2 2025 holders
4
Holder diff
-3
| Investor | Q4 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend